A study on Blood Platelets Market has been conducted to understand the landscape in 2022.
March 05-12, 2023
We conducted a survey of 545 market players of all sizes.
Number of valid answers:
Field survey 226, Internet survey 319
The survey was conducted among companies based on revenue.
Q: How big is the platelet market?
The global platelet market is estimated to garner up to USD 7 billion in revenue by the end of 2035, growing at a CAGR of up to 5% during the forecast period 2023-2035. Moreover, the market will generate revenue of around US$5 billion in 2022. The market growth can be attributed to the increasing number of blood-related diseases that increase the need for healthy blood and frequent blood transfusions. In addition, according to the World Health Organization, people with sickle cell anemia require blood transfusions every 4 to 6 weeks for long periods of time.
Furthermore, according to World Health Organization data, anemia affects 42% of children under the age of 5 and 40% of pregnant women worldwide. Approximately 21 million blood components are transfused annually in the United States.
On the other hand, the growth of the market is also attributed to the increasing number of surgeries performed, followed by the increasing incidence of traffic accidents. Approximately 310 million major procedures are performed annually worldwide, with 40-50 million in the US and 20 million in Europe. In addition, surgery is required to cure nearly 11% of diseases worldwide. In addition, approximately 3,700 people die each day in vehicle collisions and collisions with vehicles. Additionally, the United States will have over 6 million auto accidents as of 2022.
Question: What are platelets?
Platelets, also known as platelets, are small, colorless pieces of cells that form in the bone marrow. Bone marrow resembles a sponge tissue and contains red blood cells, white blood cells, and platelets. Between 150,000 and 450,000 platelets per microliter of blood constitute a normal platelet count. Thrombocytopenia is the medical term for having more than 450,000 platelets, and thrombocytopenia is less than 150,000. A person can check the number of platelets in their blood with a simple test called a complete blood count (CBC). Q: What are the key factors driving the growth of the platelet market? The key factors driving the platelet market growth are:
Increased prevalence of blood-related disorders – Blood-related disorders reduce the amount of healthy blood in the body and increase the demand for platelets. The number of Americans with sickle cell disease is about 100,000. Additionally, approximately 1 in 365 black or African American babies have SCD.
Increased number of surgical procedures
Increased incidence of organ transplantation
Increased awareness about donating blood
Increased number of trauma
Q: What are the challenges associated with the platelet market? Challenges associated with the platelet market are:
Increased risk of contagious infections – All blood given is screened and tested for possible viruses, bacteria and parasites. However, blood transfusions can spread various pathogens, including bacteria, viruses, and parasites. Bacteria are most often transmitted among them. In addition, other infections that can be transmitted are acute immune hemolysis, delayed hemolysis, and graft-versus-host disease. However, the chances of these infections are really low.
high cost of treatment
Intentional blood transfusion accidents
Question: How is the platelet market segmented?
The Platelet Market is segmented into following segments:
o Platelet dysfunction
o Perioperative indications
o Whole blood platelets
o Platelets from apheresis
By end user
o Ambulatory Surgery Center
Q: Which segment has the greatest growth based on application? The global platelet market is segmented and analyzed for supply and demand for platelet dysfunction, hemophilia, thrombocytopenia, and perioperative indications based on application. Among the four applications of platelets, the hemophilia segment is estimated to gain the largest market share over the projected time frame. Hemophilia affected approximately 210,000 people worldwide in 2020. In addition, approximately 18,400 people with hemophilia will be confirmed in the United States in 2021. In addition, another 10,000 suffer from additional bleeding disorders.
Q: Which segment has the greatest growth based on end users? The global platelet market is also segmented and analyzed for demand and supply on the basis of end-user into hospitals, ambulatory surgery centers, and other end-users. Among these three segments, the hospital segment is expected to gain a significant share. There are about 6000 hospitals in the US, about 2000 in the UK and over 11,000 in China. Q: Who are the key players in the platelets market? What are the recent developments in the market?
Major players in the platelet market are Sysmex Corporation, Haemochrom Diagnostica GmbH, Eurobio Scientific, LABiTec LAbor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., Terumo Corporation, PerkinElmer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., Aggredyne , Inc., and others.
Recent developments in the market include:
April 2019: Aggredyne, Inc.
announced US Food and Drug Administration (FDA) approval of the AggreGuide A-100 ADP Assay Test Cartridge, an in vitro diagnostic tool. Used to assess the effects of antiplatelet agents that target platelet P2Y12 receptors. The clearance will allow the company to market its products throughout the United States and expand the range of additional tests that can be performed using the A-100 equipment. February 2023: Terumo Blood and Cell Technologies
, officially launched the MUGARD WB platelet pooling set after receiving approval from the US Food and Drug Administration (FDA). It is the first platelet pool set in the United States to be approved for 7-day storage and is extremely useful during platelet shortages.
Q: Which regions are expected to offer lucrative growth opportunities for the platelets market?
The North American platelet market is projected to hold the largest market share by the end of 2035 among all other regional markets. More than 4 million people in the United States are expected to require blood transfusions each year, and approximately 43,000 pints of blood are donated each day in the United States and Canada combined. About 500,000 open heart surgeries are performed each year. Also, there are currently nearly 121,000 kidney transplant candidates in the United States.
The Asia Pacific platelet market is projected to hold the largest market share by the end of 2035 among all other regional markets. About 25,000 to 30,000 people in India require liver transplants and 50,000 suffer heart attacks each year. Additionally, over 150,000 knee surgeries are performed annually in India.
About 16 million blood donations were made in China last year in 2019, despite the impact of the COVID-19 pandemic. Additionally, blood donations in China increased more than 40-fold between 1998 and 2020. From January to April 2022, nearly 5 million blood donations were registered in China.
About the company:
Research Nester (LAMORI Pvt Ltd.) goal is to help clients achieve their goals by providing efficient business solutions. Through our diverse network of research analysts and consultants, we help our clients understand all the key aspects of business valuation, including budgeting, to deliver strategic business solutions around the world. RNPL has earned trust and a customer base in over 30 countries, with an even greater focus on expansion into other economies. We are committed to providing our clients with the best possible service and helping them expand their scope of business. Details about this release: